New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.
A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.
New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.
A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.
A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.
Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.
People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.
Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS.
Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.
People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England.